W D Simmons - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

W D Simmons

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Drug Safety|August 1, 1997

Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejectionW D Simmons, S C Rayhill, H W Sollinger

Journal of the National Cancer Institute|April 1, 1992

Clustering of adverse drug events: analysis of risk factors for cerebellar toxicity with high-dose cytarabineH M Jolson, L Bosco, M G Bufton, et al.

Transplantation Proceedings|November 22, 2005

Development of anti-human leukocyte antigen class 1 antibodies following allogeneic islet cell transplantationP I Lobo, C Spencer, W D Simmons, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Drug Safety|August 1, 1997

Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejectionW D Simmons, S C Rayhill, H W Sollinger

Journal of the National Cancer Institute|April 1, 1992

Clustering of adverse drug events: analysis of risk factors for cerebellar toxicity with high-dose cytarabineH M Jolson, L Bosco, M G Bufton, et al.

Transplantation Proceedings|November 22, 2005

Development of anti-human leukocyte antigen class 1 antibodies following allogeneic islet cell transplantationP I Lobo, C Spencer, W D Simmons, et al.

Pageof 1